Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

5,225

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

5,225 results for “moderation”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov40/100

A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov study NCT03706040. IPD Sharing: YES. Countries: 5. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

ClinicalTrials.gov study NCT04223635. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

ClinicalTrials.gov study NCT02819635. IPD Sharing: YES. Countries: 46. Publications: 13.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation

ClinicalTrials.gov study NCT03930732. IPD Sharing: YES. Countries: 24. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

ClinicalTrials.gov study NCT02353871. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome

ClinicalTrials.gov study NCT04035668. IPD Sharing: YES. Countries: 12. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant

ClinicalTrials.gov study NCT03774082. IPD Sharing: YES. Countries: 14. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

ClinicalTrials.gov study NCT04400318. IPD Sharing: YES. Countries: 13. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants

ClinicalTrials.gov study NCT03387852. IPD Sharing: YES. Countries: 8. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

ClinicalTrials.gov study NCT02874794. IPD Sharing: YES. Countries: 1. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

ClinicalTrials.gov study NCT01544595. IPD Sharing: UNDECIDED. Countries: 26. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov40/100

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov study NCT03653026. IPD Sharing: YES. Countries: 44. Publications: 9.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

ClinicalTrials.gov study NCT05421598. IPD Sharing: YES. Countries: 14. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk

ClinicalTrials.gov study NCT03315143. IPD Sharing: YES. Countries: 45. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

ClinicalTrials.gov study NCT02554773. IPD Sharing: YES. Countries: 5. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of NDI-034858 in Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov study NCT04999839. IPD Sharing: YES. Countries: 2. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

ClinicalTrials.gov study NCT02093663. IPD Sharing: YES. Countries: 7. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer

ClinicalTrials.gov study NCT03808077. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

ClinicalTrials.gov study NCT03713632. IPD Sharing: YES. Countries: 32. Publications: 5.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov40/100

Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov study NCT03912259. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.